Terbogrel

DB12204InvestigationalSmall molecule

Terbogrel has been used in trials studying the treatment of Hypertension, Pulmonary.

Mechanism: Pharmacologically active on Thromboxane A2 receptor and Thromboxane-A synthase
Curator reviewed
Formula / weight: C₂₃H₂₇N₅O₂ · 405.502 g/mol (avg)
Code names: BIBV 308 SE

Resolves to

Compound

Structure

InChIKeyXUTLOCQNGLJNSA-RGVLZGJSSA-NSMILESCC(C)(C)N\C(NC#N)=N\C1=CC(=CC=C1)C(=C/CCCC(O)=O)\C1=CC=CN=C1

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

13+ReferencesStructured and connected to the statements they support

Which drugs share a target with Terbogrel, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.